Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B

  • Technology appraisal guidance
  • TA96
  • Published: 
Download guidance (PDF)

Update information

March 2014: Implementation section updated to clarify that adefovir dipivoxil and peginterferon alfa-2a are recommended as options for treating chronic hepatitis B.

June 2013: Recommendations 1.2 to 1.4 were replaced by recommendations 1.5.13 to 1.5.15 in NICE's guideline on hepatitis B (chronic): diagnosis and management.

ISBN: 978-1-4731-7019-3